why choose us

First received: July 5, 2022

Clinical Trial: A Novel MSE Score to Predict rHCC Patients

Study Status: Completed

Recruit Status: Completed

Condition: HCC

Study Type: Observational


Official Title: A Novel MSE Score to Predict the Postoperative Prognosis of Patients With Ruptured Hepatocellular Carcinoma

Brief Summary: Develop and validate a novel scoring system based on pathological factors to predict the postoperative survival of patients with rHCC.Patients with rHCC who underwent hepatectomy were recruited from two hospitals.Exploring whether this scoring system is related to prognosis

Read more